Clinical Scorecard: Are atypical parathyroid tumors distinct from parathyroid adenomas and carcinomas? A retrospective analysis of a substantial single-center case series

At a Glance

Key Highlights

• PHPT is mostly asymptomatic (80%) and often detected incidentally; symptomatic cases (20%) present with renal and bone complications.
• Atypical parathyroid tumors (APT) show histological atypia similar to carcinoma but lack definitive invasion or metastasis.
• Ki67 proliferation index >6% correlates with aggressive behavior; APT diagnosis relies solely on histopathology without specific immunohistochemical markers.

Guideline-Based Recommendations

Diagnosis

• Diagnosis of APT is based on histopathological criteria showing atypical features without invasive growth.
• Use of Ki67 proliferation index can aid in distinguishing carcinoma (>6%) from benign lesions (<5%).
• Exclude multiglandular disease to focus on single-gland pathology.

Management

• Surgical parathyroidectomy performed by experienced endocrine surgeons is the treatment of choice.
• Postoperative monitoring of calcium and PTH levels is essential to detect persistent or recurrent disease.
• Follow-up protocols should consider the uncertain malignant potential of APT.

Monitoring & Follow-up

• Monitor serum calcium and PTH levels postoperatively to identify persistent PHPT (hypercalcemia within 6 months) or recurrent PHPT (hypercalcemia after 6 months of normocalcemia).
• Assess for postoperative complications such as hypocalcemia and hypoparathyroidism, distinguishing transient from permanent based on 6-month duration.
• Regular follow-up to detect recurrence or persistence of disease.

Risks

• Risk of nephrolithiasis and hypercalciuria in symptomatic PHPT.
• Potential for bone density loss predominantly affecting cortical bone.
• Risk of postoperative hypocalcemia and hypoparathyroidism.

Patient & Prescribing Data

Patients undergoing parathyroidectomy for single-gland PHPT including those with atypical parathyroid tumors.

Surgical excision is effective; postoperative biochemical monitoring guides further management; no specific medical therapy for APT due to uncertain malignant potential.

Clinical Best Practices

• Perform thorough preoperative biochemical and imaging evaluation to confirm single-gland disease.
• Ensure histopathological examination by specialized pathologists to differentiate APT from adenoma and carcinoma.
• Use Ki67 index as an adjunct marker to assess tumor proliferative activity.
• Implement standardized definitions for persistent and recurrent PHPT to guide postoperative follow-up.
• Monitor and manage postoperative complications promptly to reduce morbidity.

References

• World Health Organization 2022 Classification of Endocrine Tumors
• ISS/AME/SIOMMMS Guidelines 2023 on Primary Hyperparathyroidism
• Abbona et al. Study on Ki67 Proliferation Index in Parathyroid Lesions